Research plays a central role in cancer care, and in finding better ways to prevent and treat cancer. Research is also helping to find ways to improve the quality of life of people with cancer and extend their survival. In addition, through research, some patients gain access to new, possibly more effective treatments that would not otherwise be available.
For over twenty years, our oncologists have been involved in cancer research and clinical trials, staying up to date with the latest developments and offering patients the best and most advanced care for their condition.
We work closely with academic and professional institutions as well as with leading pharmaceutical and biotechnological organizations in the fields of chemotherapy and immunotherapy.
The COT participates in clinical studies as well as translation research studies and epidemiological studies. Translation research is a type of study that looks at a patient’s tumor to find features that may be related to the patient’s response to treatment and prognosis. The COT conducts its own translation research, and participates in many such studies both in Greece through its collaboration with the Hellenic Cooperative Oncology Group (HeCOG) and abroad through its collaboration with international teams, such as the Breast International Group (BIG) in Belgium, the Brain Tumors Founders Consortium (BTFC), the European Organization for Cancer Research and Treatment (EORTC) and Harvard University in the USA, among others.
In addition to translational research, our physicians are also involved in Phase II and III clinical trials of various types of solid tumors as well as in trials regarding supportive care. These are usually in collaboration with the aforementioned organizations and include the study of new drugs or new combinations or known drugs in new indications. These studies give patients access to new factors, while giving them the opportunity to contribute to the advancement of scientific knowledge.